EIGEN Bio

Eigen Bio is a biological intelligence company operating in the New York City artificial intelligence sector [1][2]. The company models the causal logic of biology to predict disease, treatment response, drug targets, and biomarkers [2]. Its platform combines a biological foundation model called Eigen-1 with a multi-omics knowledge graph named Eigenfield [2]. The commercial offering, Eigen ORIGIN, deploys the platform inside customer environments for target and biomarker discovery [2]. As of the available data, Eigen Bio operates in the biotechnology research industry [3].

Something wrong or missing? Send a correction. Fixed within 24 hours.